Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Leading industrial gas company Air Products and Chemicals Inc. ( APD - Analyst Report ) recently unveiled a couple of new superwetting surfactants (Dynol 800 and Dynol 810) and one pigment dispersant for application in the coatings industry. These environment-friendly surfactants have been geared to offer improved value and superior performance vis-à-vis the existing products.
The Dynol 800 and Dynol 810 are alkylphenol ethoxylate (“APE”) free surfactants that are designed to remove defects on difficult-to-coat substrates. APE is associated with environmental concern because of its toxicity. These new surfactants can offer better performance compared to silicones and fluorosurfactants.
While Dynol 800 provides enhanced performance in wood and plastic coatings, Dynol 810 allows impressive performance in printing inks and overprint varnishes. These novel, easy to handle products reduces surface tension and helps in controlling foam.
Air Products has also introduced the ZetaSperse 3600 dispersant which is being developed for broad utility across typical organic and carbon black pigments. This multifunctional, cost-effective pigment dispersant not only offers excellent pigment dispersion and stabilization, but also has application as a grind aid for aqueous architectural coatings, colorants and inks. ZetaSperse 3600 simplifies formulations and lessens manufacturers' need for complex formulation optimization.
Air Products offers industrial gases as well as a variety of polymer and performance chemicals and serves technology, energy, industrial and health care customers globally.
Air Products benefits from a long-term take-or-pay contract, a consolidated industry structure, diverse customer base and sustained pricing power. However, soaring energy and raw material costs pose a threat to margin expansion.
Air Products, which competes with Praxair Inc. ( PX - Analyst Report ) , currently retains a short-term Zacks #4 Rank (Sell). We have a long-term Neutral recommendation on the stock.
Read the full reports :
Analyst Report on APD
Analyst Report on PX